bioMONTR Labs Announces Laboratory Service Agreements with ViiV Healthcare

Research Triangle Park, NC, January 25, 2017 (Newswire.com) - bioMONTR Labs announced today they have entered into new Laboratory Service Agreements with ViiV Healthcare to provide HIV-1 viral load testing services for two recently announced Phase III studies anticipated to enroll more than 1000 patients.
Daniel McClernon, President and Chief Scientific Officer, for bioMONTR Labs stated, “We are pleased to provide our proprietary HIV-1 SuperLow single copy assay to assess the efficacy of the investigational medicines. bioMONTR Labs is uniquely positioned to support ongoing and new clinical trials by providing access to our highly specialized molecular test methods.”
"We are excited to provide our continued support to ViiV Healthcare towards the development of new and better therapies for those living with HIV."
Anita McClernon, Vice President & Director of Laboratory Services
Financial terms were not disclosed.
About bioMONTR Labs
bioMONTR Labs is a privately owned CLIA Certified lab located in Research Triangle Park, NC. The company offers a comprehensive menu of high-complexity molecular assays as well as other proprietary and esoteric molecular testing. Please visit www.biomontr.com for more information on the company, its management, test menu, and capabilities.
CONTACT DETAILS:
bioMONTR Labs
Anita M. McClernon, Vice President & Director of Laboratory Services
Email: amcclernon@biomontr.com
Phone: 1-866-609-3870 ext. 702
Source: bioMONTR Labs